The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Ventriculoperitoneal Shunt

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Ventriculoperitoneal Shunt

 

High impact information on Ventriculoperitoneal Shunt

 

Chemical compound and disease context of Ventriculoperitoneal Shunt

 

Biological context of Ventriculoperitoneal Shunt

 

Anatomical context of Ventriculoperitoneal Shunt

 

Associations of Ventriculoperitoneal Shunt with chemical compounds

 

Gene context of Ventriculoperitoneal Shunt

 

Analytical, diagnostic and therapeutic context of Ventriculoperitoneal Shunt

References

  1. Disconnection of the cerebral hemispheres. An alternative to hemispherectomy for the control of intractable seizures. Wilson, D.H., Culver, C., Waddington, M., Gazzaniga, M. Neurology (1975) [Pubmed]
  2. Hydrocephalic parkinsonism due to Paget's disease of bone: dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy. Ikeda, K., Kinoshita, M., Aoki, K., Tomatsuri, A. Mov. Disord. (1997) [Pubmed]
  3. Candida albicans meningitis in a 27 weeks premature infant treated with liposomal amphotericin-B (AmBisome). Jarløv, J.O., Born, P., Bruun, B. Scand. J. Infect. Dis. (1995) [Pubmed]
  4. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection. Quinn, A.L., Parada, J.P., Belmares, J., O'Keefe, J.P. The Annals of pharmacotherapy. (2005) [Pubmed]
  5. Progression of hydrocephalus during corticosteroid therapy for neurosarcoidosis. Foley, K.T., Howell, J.D., Junck, L. Postgraduate medical journal. (1989) [Pubmed]
  6. Prophylactic sulfamethoxazole and trimethoprim in ventriculoperitoneal shunt surgery. A double-blind, randomized, placebo-controlled trial. Wang, E.E., Prober, C.G., Hendrick, B.E., Hoffman, H.J., Humphreys, R.P. JAMA (1984) [Pubmed]
  7. Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Silverberg, G.D., Levinthal, E., Sullivan, E.V., Bloch, D.A., Chang, S.D., Leverenz, J., Flitman, S., Winn, R., Marciano, F., Saul, T., Huhn, S., Mayo, M., McGuire, D. Neurology (2002) [Pubmed]
  8. Elevation of transforming growth factor-beta 1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Kitazawa, K., Tada, T. Stroke (1994) [Pubmed]
  9. Metrizamide ventriculography in syringomyelia. Foster, N.L., Wing, S.D., Bray, P.F. Neurology (1980) [Pubmed]
  10. Brain choline acetyltransferase and mental function in Alzheimer disease. Baskin, D.S., Browning, J.L., Pirozzolo, F.J., Korporaal, S., Baskin, J.A., Appel, S.H. Arch. Neurol. (1999) [Pubmed]
  11. Late hydrocephalus after arrest and resolution of neonatal post-hemorrhagic hydrocephalus. Perlman, J.M., Lynch, B., Volpe, J.J. Developmental medicine and child neurology. (1990) [Pubmed]
  12. Prenatal diagnosis of a craniopharyngioma using ultrasonography and magnetic resonance imaging. Bailey, W., Freidenberg, G.R., James, H.E., Hesselink, J.R., Jones, K.L. Prenat. Diagn. (1990) [Pubmed]
  13. Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infection. Cook, A.M., Ramsey, C.N., Martin, C.A., Pittman, T. Pediatric neurosurgery. (2005) [Pubmed]
  14. Vancomycin-resistant Enterococcus ventriculo-peritoneal shunt infection cured by monotherapy with chloramphenicol. Zarroug, A.E., Golkar, L., Eachempati, S.R., Barie, P.S. Surgical infections. (2003) [Pubmed]
  15. Risk factors for latex sensitization in children with spina bifida. Pires, G., Morais-Almeida, M., Gaspar, A., Godinho, N., Calado, E., Abreu-Nogueira, J., Rosado-Pinto, J. Allergologia et immunopathologia. (2002) [Pubmed]
  16. Effects of alfentanil on intracranial pressure in children undergoing ventriculoperitoneal shunt revision. Markovitz, B.P., Duhaime, A.C., Sutton, L., Schreiner, M.S., Cohen, D.E. Anesthesiology (1992) [Pubmed]
  17. Pseudotumor cerebri associated with Sjögren's syndrome. Stanescu, D., Bodaghi, B., Huong, d.u. .L.T., Milea, D., Goulet-Salmon, B., Piette, J.C., LeHoang, P. Graefes Arch. Clin. Exp. Ophthalmol. (2003) [Pubmed]
  18. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 concentrations in cerebrospinal fluid predict ventriculoperitoneal shunt infection. Asi-Bautista, M.C., Heidemann, S.M., Meert, K.L., Canady, A.I., Sarnaik, A.P. Crit. Care Med. (1997) [Pubmed]
  19. Optimum management of pineal germ cell tumours. Smith, D.B., Newlands, E.S., Begent, R.H., Rustin, G.J., Bagshawe, K.D. Clinical oncology (Royal College of Radiologists (Great Britain)) (1991) [Pubmed]
  20. Penetration of cefuroxime into ventricular fluid in cerebrospinal fluid shunt infections. Edwards, M.S., Baker, C.J., Butler, K.M., Mason, E.O., Laurent, J.P., Cheek, W.R. Antimicrob. Agents Chemother. (1989) [Pubmed]
  21. Remifentanil and the tunnelling phase of paediatric ventriculoperitoneal shunt insertion. A double-blind, randomised, prospective study. Chambers, N., Lopez, T., Thomas, J., James, M.F. Anaesthesia. (2002) [Pubmed]
  22. Anaerobic glycolysis preceding white-matter destruction in experimental neonatal hydrocephalus. Chumas, P.D., Drake, J.M., Del Bigio, M.R., Da Silva, M., Tuor, U.I. J. Neurosurg. (1994) [Pubmed]
  23. The effect of cephalothin prophylaxis on postoperative ventriculoperitoneal shunt infections. Rieder, M.J., Frewen, T.C., Del Maestro, R.F., Coyle, A., Lovell, S. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. (1987) [Pubmed]
  24. Changes in serum cytokine concentrations after neurosurgical procedures. Osuka, K., Suzuki, Y., Saito, K., Takayasu, M., Shibuya, M. Acta neurochirurgica. (1996) [Pubmed]
  25. Presence of vitronectin and activated complement factor C9 on ventriculoperitoneal shunts and temporary ventricular drainage catheters. Lundberg, F., Li, D.Q., Falkenback, D., Lea, T., Siesjö, P., Söderström, S., Kudryk, B.J., Tegenfeldt, J.O., Nomura, S., Ljungh, A. J. Neurosurg. (1999) [Pubmed]
  26. Rifampicin as an adjunct to vancomycin therapy in MRSA septicaemia in burns. Gang, R.K., Sanyal, S.C., Mokaddas, E., Lari, A.R. Burns : journal of the International Society for Burn Injuries. (1999) [Pubmed]
  27. Brainstem tethering in Dandy-Walker syndrome: a complication of cystoperitoneal shunting. Case report. Liu, J.C., Ciacci, J.D., George, T.M. J. Neurosurg. (1995) [Pubmed]
  28. Expanding cava septi pellucidi and cava vergae in children: report of three cases. Wester, K., Kråkenes, J., Moen, G. Neurosurgery (1995) [Pubmed]
  29. Demonstration of ventriculoperitoneal shunt infection on Ga-67 citrate scintigraphy. Sun, S.S., Chuang, F.J., Chiu, K.L., Kao, C.H. Clinical nuclear medicine. (2002) [Pubmed]
  30. Magnetic resonance imaging, unstable intracranial pressure and clinical outcome in patients with normal pressure hydrocephalus. Qureshi, A.I., Williams, M.A., Razumovsky, A.Y., Hanley, D.F. Acta Neurochir. Suppl. (1998) [Pubmed]
 
WikiGenes - Universities